8 April 2024
Director/PDMR Dealings
The Board of Atlantic Lithium Limited (AIM: ALL, ASX: A11, OTCQX: ALLIF, "Atlantic Lithium" or the "Company"), the African-focused lithium exploration and development company targeting to deliver Ghana's first lithium mine, wishes to advise that Executive Chairman Neil Herbert, as a Director and person discharging managerial responsibilities ("PDMR") of the Company, has purchased in the market a total of 133,000 ordinary shares of no par value each ("Ordinary Shares"), at an average price of £0.18625 (A$0.36), equating to an aggregate value of £24,771 (A$47,590), as follows:
Director / PDMR Role | Number of Ordinary Shares purchased | Resultant number of Ordinary Shares beneficially held | Resultant percentage of issued share capital beneficially held |
Mr Neil Herbert Executive Chairman | 133,000 | 8,106,305 | 1.25% |
Following the share purchase, Directors and persons discharging managerial responsibilities ("PDMR") of the Company have purchased a total of 10,152,227 shares equating to a value of A$5,192,393 (£2,794,015) in the last 13 months.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:
PURCHASE OF ORDINARY SHARES
1. | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name: | Neil Herbert | ||||
2. | Reason for the notification | |||||
a) | Position/status: | Executive Chairman | ||||
b) | Initial notification/Amendment: | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name: | Atlantic Lithium Limited | ||||
b) | LEI: | 213800H1JY3J7BB6BN06 | ||||
4. | 1. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. | |||||
a) | Description of the financial instrument, type of instrument: Identification code: | Ordinary Shares of no par in the Company ISIN: AU0000237554 | ||||
b) | Nature of the transaction: | Purchase of Ordinary Shares
| ||||
c) | Price(s) and volume(s):
|
| ||||
d) | Aggregated information:
| Purchase of 133,000 Ordinary Shares at an average price of £0.18625 (AUD0.36) per Ordinary Share
| ||||
e) | Date of the transaction: | 5 April 2024 | ||||
f) | Place of the transaction: | AIM (ALL) |
Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.
For any further information, please contact:
Atlantic Lithium Limited
Neil Herbert (Executive Chairman)
Amanda Harsas (Finance Director and Company Secretary)
www.atlanticlithium.com.au | ||||
IR@atlanticlithium.com.au | ||||
Tel: +61 2 8072 0640 | ||||
SP Angel Corporate Finance LLP Nominated Adviser Jeff Keating Charlie Bouverat Tel: +44 (0)20 3470 0470 |
Yellow Jersey PR Limited Charles Goodwin Bessie Elliot Tel: +44 (0)20 3004 9512
|
Canaccord Genuity Limited Financial Adviser: Raj Khatri (UK) / Duncan St John, Christian Calabrese (Australia)
Corporate Broking: James Asensio Tel: +44 (0) 20 7523 4500 |
|
Notes to Editors:
About Atlantic Lithium
Atlantic Lithium is an AIM and ASX-listed lithium company advancing its flagship project, the Ewoyaa Lithium Project, a significant lithium spodumene pegmatite discovery in Ghana, through to production to become the country's first lithium-producing mine.
The Definitive Feasibility Study for the Project indicates the production of 3.6Mt of spodumene concentrate over a 12-year mine life, making it one of the largest spodumene concentrate mines in the world.
The Project, which was awarded a Mining Lease in October 2023, is being developed under an earn-in agreement with Piedmont Lithium Inc.
Atlantic Lithium holds a portfolio of lithium projects within 509km2 and 774km2 of granted and under-application tenure across Ghana and Côte d'Ivoire respectively, which, in addition to the Project, comprises significantly under-explored, highly prospective licences.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.